I am not - the results had already been preannounced and triple digit product revenue gains out of virtually nothing don't mean much to me.
The reason for cancelling the serious H issuance was simply that they were not able to sell those shares at an acceptable price. Remember the offering has been announced several weeks ago with Northland Capital having already been picked as the book-runner.
Wondering why management doesn't not buy more shares if they are so much committed to the great prospects of the company. They could buy 4 mln shares at $3 for example which would be a really strong signal for investors.
why should it move up ? HSOL investors have been screwed big time and the shares look heavily overvalued compared to peers given the 3x overpayment for Q-Cells.
Even after the merger the company will continue to lack peers in many aspects. The company will have to deliver profitable growth going forward to grow into the current valuation. Unfortunately I don't see this happen anytime soon.
Actually given how much HSOL was forced to overpay for Q-Cells I see substantial downside for the shares here as they appear way overpriced when compared to peers - at least 50% or even more.
But at least the risk of bankruptcy looks pretty low right now given the new 94% ownership of HSH.
actually MSFT might have noticed them to come up with a much better offer or otherwise the contract will be gone. Now they came up with new terms and MSFT has time to rethink it
there were no delays - the backlog consists of just two power plants currently under construction and with the ongoing construction progress it gets converted to revenue.
But within a few quarters the construction of the plants will be finished and the company has failed to secure additional contracts so far. This should change pretty soon or Gemma will sit idle in 2016.
it is delighting to see that Mr.Market finally gets things right - the stock has already given back all of the undeserved gains from Andy's old news recycling center.
so tell me what did they do to adress the debt situation ? Most of their rigs will sit idle in Q3 2015 and they still have $500 mln in short term financing needs for FY15 (debt maturities and newbuild semisub) - unless some kind of miracle happens they will be bankrupt within a few months
they wrote "elected" - but in fact they are forced to do it. Remember they also try to make you believe that the price for Q-Cells was fair.
(...) that the holders have the right, pursuant to the terms of the indenture governing the Notes, to require the Company to repurchase all or a portion of their Notes (the "Put Right").
There's nothing voluntary in this action. Every noteholder who makes use of his put right (and all of them will) will have to be repaid in full.
Actually the ADR is worth FAR LESS than its current price - enterprise value has reached the size of highly profitable and debt free market leader First Solar.
Better than expected US business made up for weak business trends in the UK. This will continue during FY15 as the UK has plenty of issues e.g. the loss of a private label customer, forex headwinds and severe competition.
They have the cash on hand or will at least be able to get the money from their parent company to redeem the convert. So this is neither positive or negative at first glance. From a balance sheet perspective some cash and some debt will be erased causing the balance sheet to shrink by that amount on both sides.
The notes contain a put option which allows investors to put them back to the company in 2015 and that's why HSOL HAS to redeem them soon. This is by no means a voluntary action by the company and if anything it is rather negative as the company will suffer a material cash outflow.
none - the bond issue has been discussed on almost each conference call so far. The company is redeeming the convert from cash on hand or by borrowing from their parent. This is a well known non-issue.
it is just the enterprise value - that means current market cap plus debt load to get to the .8 bln for HSOL
not really - Q-Cells is still losing money and despite not formally merged the companies already previously worked together as they shared the same parent company.
At current share prices the enterprise value of the combined company is close to market leaders like FSLR or SPWR despite much weaker margins and ongoing losses.
This is absurd und will be corrected over time. I see HSOL shares being overvalued by at least 50% here.
they won't sell as the new shares make them control the company completely - but they ousted current HSOL shareholders through this move
Actually the shares should be down by 50% or even more as the deals' main rationale was to oust current HSOL shareholders.The two entities were owned by the same parent anyway so they were already able to manage orders and shipments with regards to tariffs.
HSOL was effectively ordered to overpay at least three times for the Q-Cells business in order to get the full control over the merged entity and leave as little on the table for current shareholders as possible.
Utter nonsense. Q-Cells announced a profit for Q1 FY14 but remained silent for Q2 and Q3 which is pretty much telling I guess. The combined entity will continue to record sizeable losses but the deal should be mildly accreditive overall which means somewhat lower losses than when acting as separate companies. Anyway the major dilution suffered by HSOL shareholders today will make the current share price unsustainable going forward.
why switching from soon to be bankrupt NADL to VERY soon bankrupt FRO ? I don't get it. They have a convert due in a few weeks.